Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal Cancer

NCT02213497 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

RADIATION: 18F-FDG (Fluorodeoxyglucose) PET
DRUG: Carboplatin
DRUG: Paclitaxel

Sponsor

Abramson Cancer Center at Penn Medicine